Rights and permissions
About this article
Cite this article
Benlysta will initially share the market with Rituxan for SLE. Pharmacoecon. Outcomes News 623, 11 (2011). https://doi.org/10.2165/00151234-201106230-00031
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106230-00031